Related Experiment Videos
Lack of a pharmacokinetic interaction between ciprofloxacin and fenbufen
1Wolfson Unit of Clinical Pharmacology, University of Newcastle, U.K.
Journal of Clinical Pharmacy and Therapeutics
|August 1, 1994
Abstract:
The possible effects of a three day pretreatment with fenbufen on the pharmacokinetics of a single oral (500 mg) dose of ciprofloxacin were evaluated in a randomized crossover study in a group of eight healthy male volunteers. Fenbufen pretreatment was shown to have no significant effect on ciprofloxacin pharmacokinetics.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Determination of Dabigatran Concentration in Human Plasma and Breast Milk.
International journal of analytical chemistry·2021
Correlation between Trunk-Pelvis Inter-Segmental Coordination Parameters during Walking and Disability Level in Chronic Low Back Pain Patients.
Journal of biomedical physics & engineering·2018
Interleukin-6 secreted by oral cancer- associated fibroblast accelerated VEGF expression in tumor and stroma cells.
Cellular and molecular biology (Noisy-le-Grand, France)·2017
Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017
Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden.
The pharmacogenomics journal·2016
Influence of CYP2C9 polymorphism on the fall in International Normalized Ratio in patients interrupting warfarin therapy before elective surgery.
Journal of thrombosis and haemostasis : JTH·2015
Impact of pharmacist-initiated educational interventions on improving medication reconciliation practice in geriatric inpatients during hospital admission in Vietnam.
Journal of clinical pharmacy and therapeutics·2022
Evaluation of off-label anti-vascular endothelial growth factor and steroid implant medication uses in macular edema due to retinal vein occlusion in Turkey.
Journal of clinical pharmacy and therapeutics·2022
A descriptive analysis of pharmacological management of aggression and/or agitation in patients with traumatic brain injury in a Southwest Virginia inpatient population.
Journal of clinical pharmacy and therapeutics·2022
Effects of caregiver counselling on medication persistence and adherence in patients with dementia at a pharmacist-managed clinic: A pilot study.
Journal of clinical pharmacy and therapeutics·2022
The 50% and 95% effective doses of remimazolam tosilate with adjuvant sufentanil for sedation in patients with liver cirrhosis undergoing oesophagogastric varices screening endoscopy.
Journal of clinical pharmacy and therapeutics·2022
Tumour necrosis factor inhibitor combined with intravenous immunoglobulin and heparin for treatment of recurrent spontaneous abortion: A two-centre, retrospective, cohort study.
Journal of clinical pharmacy and therapeutics·2022
Multi-database pharmacovigilance identifies disproportionate reporting of hepatobiliary events with avacopan: an integrative study with network pharmacology and interpretable machine learning.
Naunyn-Schmiedeberg's archives of pharmacology·2026
AI-Guided Discovery of Natural-Product-Inspired Scaffolds as Dual P-gp/BCRP Inhibitors to Overcome Cancer Multidrug Resistance.
Journal of medicinal chemistry·2026
Real-world outcomes of sitagliptin and sitagliptin/metformin single-pill combination treatment in diverse type 2 diabetes populations (DIVERSITY study).
Frontiers in clinical diabetes and healthcare·2026
Polypharmacy status and its related risk factors among elderly patients with dyslipidemia: Iranian multi-center osteoporosis study (IMOS) 2021.
Journal of diabetes and metabolic disorders·2026